ICE Global Consulting Acquires CliniStart

Elligo Health Research Acquires ClinEdge in $135M Transaction

September 23, 2021

Healthcare Services

Elligo Health Research completed the acquisition of ClinEdge (including GuideStar Research and BTC of New Bedford) as part of a $135 million financing led by Morgan Stanley Expansion Capital and Ally Bridge Group, with participation from Norwest Venture Partners and existing investors. The deal expands Elligo’s global scale and capabilities by combining ClinEdge’s research practice management and clinical services with Elligo’s IntElligo technology, EHR-derived data access, and trial-acceleration platform.

Godspeed Capital Invests in Infrastructure Consulting & Engineering (ICE)

April 3, 2024

Engineering Services

Godspeed Capital has made a strategic investment in Infrastructure Consulting & Engineering (ICE) to establish ICE as a transportation-focused engineering and consulting platform serving the Southeastern U.S. ICE, headquartered in Columbia, South Carolina, operates 23 offices with more than 500 professionals and will continue to be led by its existing management team, which will retain a significant equity stake. Financial terms were not disclosed.

ERT Merges with Bioclinica to Create Global Clinical Trial Endpoint Leader

December 10, 2020

Healthcare Services

ERT has merged with Bioclinica to create a global leader in clinical trial endpoint technology, combining Bioclinica's imaging and eClinical capabilities with ERT's expertise in eCOA, cardiac safety, respiratory and wearables. The transaction was completed in 2021 with Cinven (Bioclinica's owner) becoming a significant minority shareholder in ERT alongside Nordic Capital, Astorg and Novo Holdings A/S.

Eximia Research Acquires Integrated Clinical Trial Services (ICTS)

October 16, 2024

Healthcare Services

Eximia Research, a Raleigh-based integrated clinical research network, has acquired Integrated Clinical Trial Services, Inc. (ICTS), a dedicated clinical research clinic in West Des Moines, Iowa. The acquisition expands Eximia’s Midwest footprint and increases local patient access to clinical trials across multiple therapeutic areas including pediatrics, neurology and dermatology.

Norstella and Citeline Merge to Create $5B Global Pharma Technology Company

June 28, 2022

Data & Analytics

Norstella (the group of Evaluate, MMIT, Panalgo and The Dedham Group) announced an agreement to merge with Citeline (formerly Pharma Intelligence) to form a combined global pharmaceutical technology and intelligence business valued at about $5 billion. The combination brings clinical trial intelligence, commercial data and real‑world analytics together to offer an end‑to‑end suite of solutions for life sciences companies; the deal involves financial sponsors including Hg (Norstella) and Warburg Pincus (Citeline).

Greenphire Acquires Clincierge to Expand Clinical Trial Participant Support

February 1, 2024

Healthcare Services

Greenphire, a Thoma Bravo-backed provider of clinical trial software, has acquired Clincierge, a concierge travel and logistics service for clinical trial participants. The acquisition expands Greenphire's participant support capabilities by integrating high-touch travel and logistics services with its payment and trial-support technology to improve participant experience and trial efficiency.